secwatch.observer — SEC 8-K summary
======================================

Issuer:     Gyrodyne, LLC (GYRO)
CIK:        0001589061
Form:       8-K
Filed at:   2023-10-12T23:59:59+00:00
Accession:  0001437749-23-028132
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Gyrodyne reports estimated NAV of $20.14/share, updates on entitlement delays and activist costs
--------------------------------------------------------------------------------

- Estimated liquidating value $20.14 per share at Q2 2023, up $4.61 from Dec 2021, driven by $11.1M real estate value increase.
- Cortlandt Manor received medical district designation (150K sq ft office, 4K retail) in March 2023; Smithtown final approvals expected late 2023/early 2024.
- Article 78 proceeding challenging Smithtown subdivision reassigned to second new judge; motion to dismiss filed June 2022 remains undecided.
- Shareholder activist campaign (Star Equity) cumulative cost ~$600K through June 2023; total may reach $1M; D&O insurance coverage being pursued.
- Company seeking supplemental funding before year-end; $9.6M debt at fixed rates 3.75-3.85% unaffected by Fed hikes; annual debt service ~$650K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1589061/000143774923028132/0001437749-23-028132-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1589061/000143774923028132/gyrllc20231012_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-028132

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer